NCT03861702: A trial that was reported late by Nelson Yee
This trial has reported, although it was 206 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03861702 |
|---|---|
| Title | A Phase II Study to Evaluate the Efficacy of Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: Big Ten Cancer Research Consortium BTCRC-GI15-067 |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 2, 2020 |
| Completion date | Aug. 16, 2023 |
| Required reporting date | Aug. 15, 2024, midnight |
| Actual reporting date | March 10, 2025 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | 206 |